Marcia S. Brose
Elite in Thyroid Cancer

Dr. Marcia S. Brose

Oncology
Jefferson Health
Jefferson Torresdale Hospital
10800 Knights Road, 
Philadelphia, PA 
Accepting New Patients
Elite in Thyroid Cancer
Jefferson Health
Jefferson Torresdale Hospital
10800 Knights Road, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marcia Brose is an Oncologist in Philadelphia, Pennsylvania. Dr. Brose is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Brose is currently accepting new patients.

Her clinical research consists of co-authoring 81 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 60 articles and participated in 3 clinical trials in the study of Thyroid Cancer.

Graduate Institution
Weill Cornell Medical College
Residency
Hospital of the University of Pennsylvania
Specialties
Oncology
Licenses
Otolaryngology in PA
Board Certifications
Medical Oncology
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Jefferson Bucks Hospital
Jefferson Frankford Hospital
Jefferson Torresdale Hospital
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Jefferson Torresdale Hospital
10800 Knights Road, Philadelphia, PA 19114
Call: 215-890-3030

Additional Areas of Focus

Dr. Brose has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Thyroid Cancer
Thyroid Nodule

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Enrollment Status: Approved_for_marketing
Publish Date: January 17, 2025
Intervention Type: Drug
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Enrollment Status: Unknown
Publish Date: October 15, 2021
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
View 3 Less Clinical Trials

82 Total Publications

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 19, 2025
View All 82 Publications
Similar Doctors
Distinguished in Thyroid Cancer
Dr. Jessica R. Bauman
Oncology | Transplant Surgery
Distinguished in Thyroid Cancer
Dr. Jessica R. Bauman
Oncology | Transplant Surgery

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (10.0 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances

Jessica Bauman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Bauman is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Polymorphous Low Grade Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Distinguished in Thyroid Cancer
Dr. Danielle E. Lann
Oncology
Distinguished in Thyroid Cancer
Dr. Danielle E. Lann
Oncology

HMH - Endocrine Surgery - Neptune

19 Davis Avenue, Floor 4, 
Neptune, NJ 
 (51.2 miles away)
732-776-4770
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Danielle Lann is an Oncologist in Neptune, New Jersey. Dr. Lann is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, and Familial Isolated Hyperparathyroidism.

Distinguished in Thyroid Cancer
Carolyn Grande, NP
Nurse Practitioner | Hematology | Oncology
Distinguished in Thyroid Cancer
Carolyn Grande, NP
Nurse Practitioner | Hematology | Oncology

Abramson Cancer Center Perelman 2nd Floor West

3400 Civic Center Boulevard, West Pavilion, 2nd Floor, 
Philadelphia, PA 
 (14.0 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carolyn Grande is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Ms. Grande is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Follicular Thyroid Cancer, Papillary Thyroid Cancer, Thyroid Cancer, and Anaplastic Thyroid Cancer. Ms. Grande is currently accepting new patients.

VIEW MORE THYROID CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brose's expertise for a condition
ConditionClose
  • Elite
  • Medullary Thyroid Carcinoma
    Dr. Brose is
    Elite
    . Learn about Medullary Thyroid Carcinoma.
    See more Medullary Thyroid Carcinoma experts
  • Papillary Thyroid Cancer
    Dr. Brose is
    Elite
    . Learn about Papillary Thyroid Cancer.
    See more Papillary Thyroid Cancer experts
  • Thyroid Cancer
    Dr. Brose is
    Elite
    . Learn about Thyroid Cancer.
    See more Thyroid Cancer experts
  • Distinguished
  • Anaplastic Thyroid Cancer
    Dr. Brose is
    Distinguished
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Endometrial Cancer
    Dr. Brose is
    Distinguished
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Follicular Thyroid Cancer
    Dr. Brose is
    Distinguished
    . Learn about Follicular Thyroid Cancer.
    See more Follicular Thyroid Cancer experts
  • Advanced
  • Neuroendocrine Tumor
    Dr. Brose is
    Advanced
    . Learn about Neuroendocrine Tumor.
    See more Neuroendocrine Tumor experts
  • Experienced
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Brose is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • EGFR Positive Lung Cancer
    Dr. Brose is
    Experienced
    . Learn about EGFR Positive Lung Cancer.
    See more EGFR Positive Lung Cancer experts
  • Fibrosarcoma
    Dr. Brose is
    Experienced
    . Learn about Fibrosarcoma.
    See more Fibrosarcoma experts
  • Large-Cell Lung Carcinoma
    Dr. Brose is
    Experienced
    . Learn about Large-Cell Lung Carcinoma.
    See more Large-Cell Lung Carcinoma experts
  • Laryngeal Nerve Damage
    Dr. Brose is
    Experienced
    . Learn about Laryngeal Nerve Damage.
    See more Laryngeal Nerve Damage experts
  • Lung Adenocarcinoma
    Dr. Brose is
    Experienced
    . Learn about Lung Adenocarcinoma.
    See more Lung Adenocarcinoma experts
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.